DEFA14A 1 d123756ddefa14a.htm DEFA14A DEFA14A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.     )

 

 

Filed by the Registrant  ☒

Filed by a Party other than the Registrant  ☐

Check the appropriate box:

 

  Preliminary Proxy Statement
  Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
  Definitive Proxy Statement
  Definitive Additional Materials
  Soliciting Material under §240.14a-12

HCA Healthcare, Inc.

(Name of Registrant as Specified in Its Charter)

Not Applicable

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

  No fee required.
  Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
  (1)  

Title of each class of securities to which transaction applies:

 

     

  (2)  

Aggregate number of securities to which transaction applies:

 

     

  (3)  

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

     

  (4)  

Proposed maximum aggregate value of transaction:

 

     

  (5)  

Total fee paid:

 

     

  Fee paid previously with preliminary materials:
  Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by Registration Statement number, or the Form or Schedule and the date of its filing.
  (1)  

Amount Previously Paid:

 

     

  (2)  

Form, Schedule or Registration Statement No.:

 

     

  (3)  

Filing Party:

 

     

  (4)  

Date Filed:

 

     

 

 

 


                                  
                        
   

 

Your Vote Counts!

          
 

 

HCA HEALTHCARE, INC.

 

2021 Annual Meeting

Vote by April 27, 2021

11:59 PM ET

.

 

             
     

 

HCA HEALTHCARE, INC.

ATTN: CORPORATE SECRETARY

ONE PARK PLAZA

NASHVILLE, TN 37203

 

LOGO         

 

   
     

    

     
 
 
              
 
 

            D39767-P50764

                                       
            

You invested in HCA HEALTHCARE, INC. and it’s time to vote!

You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the stockholder meeting to be held on April 28, 2021.

Get informed before you vote

View the Notice and Proxy Statement and 2020 Annual Report online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 14, 2021. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.

 

LOGO

 

 

    * Please check the meeting materials for any special requirements for meeting attendance.

 

V1


Vote at www.ProxyVote.com

 

 

THIS IS NOT A VOTABLE BALLOT

This is an overview of the proposals being presented at the

upcoming stockholder meeting. Please follow the instructions on

the reverse side to vote these important matters.

 

    Voting Items   Board
Recommends
 

1.

 

Election of Directors

 

Nominees:

 

 

1a.

  Thomas F. Frist III   LOGO  For
 

1b.

  Samuel N. Hazen   LOGO  For
 

1c.

  Meg G. Crofton   LOGO  For
 

1d.

  Robert J. Dennis   LOGO  For
 

1e.

  Nancy-Ann DeParle   LOGO  For
 

1f.

  William R. Frist   LOGO  For
 

1g.

  Charles O. Holliday, Jr.   LOGO  For
 

1h.

  Michael W. Michelson   LOGO  For
 

1i.

  Wayne J. Riley, M.D.   LOGO  For
 

2.

  To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2021.   LOGO  For
 

3.

  Advisory vote to approve named executive officer compensation.   LOGO  For
 

4.

  Stockholder proposal, if properly presented at the meeting, requesting that the Board of Directors take the steps necessary to allow stockholders to act by written consent.   LOGO  Against
 

5.

  Stockholder proposal, if properly presented at the meeting, requesting a report on the feasibility of increasing the impact of quality metrics on executive compensation.   LOGO  Against

NOTE: In their discretion, the proxies are authorized to vote upon any other business that may properly come before the meeting or any postponement or adjournment thereof.

   
      

 

Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Sign up for E-delivery”.

                                         D39768-P50764